Hellman Jordan Management Company’s Zimmer Biomet ZBH Stock Holding History

Hellman Jordan Management Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,190	Closed	-$536K	–	73
2022 Q1	$536K	Buy	4,190 +516	+14%	+$62.2K	0.58%	50
2021 Q4	$453K	Sell	3,674 -4,310	-54%	-$564K	0.54%	52
2021 Q3	$1.13M	Buy	7,984 +3,390	+74%	+$499K	1.6%	26
2021 Q2	$717K	Buy	+4,594	New	+$744K	1.27%	32

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hellman Jordan Management Company's ZBH Position: Q2 2022 in Review

Hellman Jordan Management Company sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 4,190 shares — an estimated $536K sold.

Hellman Jordan Management Company first reported a position in ZBH in Q2 2021 and held it in 4 quarters. The position peaked at $1.13M in Q3 2021. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Hellman Jordan Management Company reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Hellman Jordan Management Company sold 4,190 Zimmer Biomet shares in Q2 2022, an estimated $536K.
Hellman Jordan Management Company first reported a position in Zimmer Biomet in Q2 2021 and held it in 4 quarters.
Hellman Jordan Management Company's Zimmer Biomet position peaked at $1.13M in Q3 2021.
957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Hellman Jordan Management Company's 13F filing for Q2 2022, filed 27 Sep 2022.